Primary
What is primary ovarian insufficiency (POI)?
Primary ovarian insufficiency (POI), also known as premature ovarian failure, happens when a woman's ovaries stop working normally before she is 40.
Many women naturally experience reduced fertility when they are about 40 years old. They may start getting irregular menstrual periods as they transition to menopause. For women with POI, irregular periods and reduced fertility start before the age of 40. Sometimes it can start as early as the teenage years.
POI is different from premature menopause. With premature menopause, your periods stop before age 40. You can no longer get pregnant. The cause can be natural or it can be a disease, surgery, chemotherapy, or radiation. With POI, some women still have occasional periods. They may even get pregnant. In most cases of POI, the cause is unknown.
What causes primary ovarian insufficiency (POI)?In about 90% of cases, the exact cause of POI is unknown.
Research shows that POI is related to problems with the follicles. Follicles are small sacs in your ovaries. Your eggs grow and mature inside them. One type of follicle problem is that you run out of working follicles earlier than normal. Another is that the follicles are not working properly. In most cases, the cause of the follicle problem is unknown. But sometimes the cause may be:
- Genetic disorders such as Fragile X syndrome and Turner syndrome
- A low number of follicles
- Autoimmune diseases, including thyroiditis and Addison disease
- Chemotherapy or radiation therapy
- Metabolic disorders
- Toxins, such as cigarette smoke, chemicals, and pesticides
Certain factors can raise a woman's risk of POI:
- Family history. Women who have a mother or sister with POI are more likely to have it.
- Genes. Some changes to genes and genetic conditions put women at higher risk for POI. For example, women Fragile X syndrome or Turner syndrome are at higher risk.
- Certain diseases, such as autoimmune diseases and viral infections
- Cancer treatments, such as chemotherapy and radiation therapy
- Age. Younger women can get POI, but it becomes more common between the ages of 35-40.
The first sign of POI is usually irregular or missed periods. Later symptoms may be similar to those of natural menopause:
- Hot flashes
- Night sweats
- Irritability
- Poor concentration
- Decreased sex drive
- Pain during sex
- Vaginal dryness
For many women with POI, trouble getting pregnant or infertility is the reason they go to their health care provider.
What other problems can primary ovarian insufficiency (POI) cause?Since POI causes you to have lower levels of certain hormones, you are at greater risk for other health conditions, including:
- Anxiety and depression. Hormonal changes caused by POI can contribute to anxiety or lead to depression.
- Dry eye syndrome and eye surface disease. Some women with POI have one of these eye conditions. Both can cause discomfort and may lead to blurred vision. If not treated, these conditions can cause permanent eye damage.
- Heart disease. Lower levels of estrogen can affect the muscles lining the arteries and can increase the buildup of cholesterol in the arteries. These factors increase your risk of atherosclerosis (hardening of the arteries).
- Infertility.
- Low thyroid function. This problem also is called hypothyroidism. The thyroid is a gland that makes hormones that control your body's metabolism and energy level. Low levels of thyroid hormones can affect your metabolism and can cause very low energy, mental sluggishness, and other symptoms.
- Osteoporosis. The hormone estrogen helps keep bones strong. Without enough estrogen, women with POI often develop osteoporosis. It is a bone disease that causes weak, brittle bones that are more likely to break.
To diagnose POI, your health care provider may do:
- A medical history, including asking whether you have relatives with POI
- A pregnancy test, to make sure that you are not pregnant
- A physical exam, to look for signs of other disorders that could be causing your symptoms
- Blood tests, to check for certain hormone levels. You may also have a blood test to do a chromosome analysis. A chromosome is the part of a cell that contains genetic information.
- A pelvic ultrasound, to see whether or not the ovaries are enlarged or have multiple follicles
Currently, there is no proven treatment to restore normal function to a woman's ovaries. But there are treatments for some of the symptoms of POI. There are also ways to lower your health risks and treat the conditions that POI can cause:
- Hormone replacement therapy (HRT).HRT is the most common treatment. It gives your body the estrogen and other hormones that your ovaries are not making. HRT improves sexual health and decreases the risks for heart disease and osteoporosis. You usually take it until about age 50; that's about the age when menopause usually begins.
- Calcium and vitamin D supplements. Because women with POI are at higher risk for osteoporosis, you should take calcium and vitamin D every day.
- In vitro fertilization (IVF). If you have POI and you wish to become pregnant, you may consider trying IVF.
- Regular physical activity and a healthy body weight.Getting regular exercise and controlling your weight can lower your risk for osteoporosis and heart disease.
- Treatments for associated conditions. If you have a condition that is related to POI, it is important to treat that as well. Treatments may involve medicines and hormones.
NIH: National Institute of Child Health and Human Development
Primary FDA Approved Drugs
- Treatment of biopsy-confirmed, primary superficial basal cell carcinoma (sbcc).
- Works through the induction of interferon and other cytokines.
- Treating hypercholesterolemias with reduction of food effect.
- Treating hypertriglyceridemias with reduction of food effect.
- Treating primary hypercholesterolemia and mixed dyslipidemia.
- Treating severe hypertriglyceridemia.
- Testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; primary hypogonadism (congenital or acquired); hypogonadotropic hypogonadism (congenital or acquired)..
- Treatment of pediatric patients 8 to 17 years of age with heterozygous familial hypercholesterolemia (hefh).
- Use of rosuvastatin calcium for the primary prevention of cardiovascular disease in individuals without clinically evident coronary heart disease but with increased risk factors.
- Use of rosuvastatin calcium to reduce elevated total-c, ldl-c, apob, nonhdl-c or tg levels; to increase hdl-c in adult patients with primary hyperlipidemia or mixed dyslipidemia; and to slow the progression of atherosclerosis..
- A method of treating or preventing ileus.
- A method to accelerate the time to gastrointestinal recovery by administering about 12 mg of alvimopan to the patient from about 30 to 60 minutes prior to surgery.
- Accelerating the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis.
- Treating a subject undergoing abdominal surgery by administering alvimopan to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis.
- Management of postherpetic neuralgia (phn) in adults.
- Treatment of moderate-to-severe primary restless leg syndrome in adults.
- Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures.
- Adjuncitve therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprtein b, triglycerides and to increase hdl-c in adult patients with primary hyperlipidemia or mixed dyslipidemia.
- Treatment of moderate to severe primary restless legs syndrome (rls).
- A method of reducing the capacity of extended release nicotinic acid to provoke a flushing reaction by pretreating an individual with a flush inhibiting agent prior to the administration of the extended release nicotinic acid.
- Method of treating hyperlipidemia with nicotinic acid by dosing once per day in the evening or at night.
- Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night, with pretreatment with a flush inhibitin agent such as aspirin.
- Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night.
- Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or a t night, with pretreatment with a flush inhibitin agent such as aspirin.
- Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or at night.
- Reduction in tg by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
- Reduction in tg by dosing once per day in the evening or at night.
- Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
- Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night.
- Treatment of primary biliary cholangitis (pbc).
- Adjunctive therapy to diet in adults to reduce ldl-c, total-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v).
- Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v).
- Reduction of elevated plasma sterol and/or stanol levels in a mammal.
- To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate.
- To reduce plasma cholesterol levels in a mammal.
Felter's Materia Medica on Primary
   The fresh, green stems and the flowers of Selenicereus grandiflorus (L.) Britt. & Rose (and other Selenicereus speciesMM) (Cereus grandiflorus,... / ...at the mental, cerebral, gastric, and other effects are secondary to and dependent largely upon the primary effects of the drug upon the heart; others believe its action depends chiefly upon the nervo... / ...organ were held with a strong band, it is often the most prompt of all cardiac remedies. It is a good remedy in the heart troubles produced by to1
   The dried leaves and flowering tops of one or several species of Grindeliaas Grindelia camporum, Greene; or Grindelia squarrosa (Pursh), Dunal.... / ...ys are excited by them and diuresis is increased, while upon the bronchial membranes they produce a primary increase of secretion followed by a lessened expectoration and diminution of the rate of bre... / ...over the spleen, sallow skin, debility and indigestion, with gastric distress. The bitter taste of grindelia is best disguised by chloroform.1
   The leaves and flowering or fruiting tops of Hyoscyamus niger, Linné (Nat. Ord. Solanaceae). Europe; naturalized in waste places in the United... / ...liriant than its congeners and it is less likely to cause cerebral hyperaemia. Under hyoscyamus the primary stimulation observed under belladonna and stramonium and their alkaloids may be absent, or a... / ...conditions best. Hence its value in nervous headache, the headache of debility, the vague pains of so-called chronic rheumatism, idiopath1
   The ripe seeds of Linum usitatissimum, Linné (Nat. Ord. Linaceae). Levant and southern Europe; cultivated. Common Names: Flaxseed,... / ...issues should be borne in mind. Equal parts of linseed oil and lime water form Carron Oil, the best primary dressing for burns and scalds. Linseed meal added to the wash water will assist in removing ... / ...given in daily repeated doses of 1 to 2 ounces. Linseed oil may be given freely in poisoning by alkalies, when other bland oils are not at hand.1
   The dried, ripe seed of Physostigma venenosum, Balfour (Nat. Ord. Leguminosae). A climbing perennial, native of Calabar, in the Gulf of Guinea, on... / ...s, in human poisoning, to dilate he concludes: that when the alkaloid is in sufficient amount the primary oculo-motor stimulation is followed by oculo-motor palsy. The view that the drug acts by c... / ...drug has not therefore had a fair trial. It is one of the suggested antidotes for strychnine poisoning, the alkaloid being preferred. For all of1
   The dried root of Stillingia sylvatica, Linné (Nat. Ord. Euphorbiaceae). Southern United States growing in sandy soils. Dose, 5 to 60... / ... of tissue waste with tardy repair of structure. While sometimes used early in syphilis, during the primary stage, we can see no reason for its use before broken-down products begin to appear as it is... / ...from difficult breathing experienced by consumptives, as well as the pains in the limbs so frequently a torture to this class of sufferers.1